H.U. Group Holdings, Inc.

TSE:4544 Stock Report

Market Cap: JP¥140.5b

H.U. Group Holdings Valuation

Is 4544 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 4544 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4544 (¥2473.5) is trading below our estimate of fair value (¥4132.33)

Significantly Below Fair Value: 4544 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4544?

Key metric: As 4544 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 4544. This is calculated by dividing 4544's market cap by their current revenue.
What is 4544's PS Ratio?
PS Ratio0.6x
SalesJP¥240.39b
Market CapJP¥140.54b

Price to Sales Ratio vs Peers

How does 4544's PS Ratio compare to its peers?

The above table shows the PS ratio for 4544 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.8x
4694 BML
0.8x2.4%JP¥110.9b
9158 CUC
1.3x19.2%JP¥50.0b
7840 France Bed HoldingsLtd
0.7xn/aJP¥42.8b
6197 Solasto
0.3x4.2%JP¥44.0b
4544 H.U. Group Holdings
0.6x4.0%JP¥140.5b

Price-To-Sales vs Peers: 4544 is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (0.8x).

Price to Sales Ratio vs Industry

How does 4544's PS Ratio compare vs other companies in the JP Healthcare Industry?

6 CompaniesPrice / SalesEstimated GrowthMarket Cap
3151 Vital KSK Holdings
0.1xn/aUS$364.96m
3055 Hokuyaku Takeyama HoldingsInc
0.07xn/aUS$118.78m
3154 Medius Holdings
0.06xn/aUS$112.13m
2689 OLBA HEALTHCARE HOLDINGS
0.1xn/aUS$77.45m
4544 0.6xIndustry Avg. 0.5xNo. of Companies8PS00.40.81.21.62+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 4544 is expensive based on its Price-To-Sales Ratio (0.6x) compared to the JP Healthcare industry average (0.5x).

Price to Sales Ratio vs Fair Ratio

What is 4544's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4544 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.6x
Fair PS Ratio0.9x

Price-To-Sales vs Fair Ratio: 4544 is good value based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (0.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 4544 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥2,473.50
JP¥2,348.00
-5.1%
9.6%JP¥2,700.00JP¥2,100.00n/a5
Nov ’25JP¥2,611.00
JP¥2,388.00
-8.5%
8.4%JP¥2,700.00JP¥2,100.00n/a5
Oct ’25JP¥2,680.00
JP¥2,388.00
-10.9%
8.4%JP¥2,700.00JP¥2,100.00n/a5
Sep ’25JP¥2,679.00
JP¥2,348.00
-12.4%
6.3%JP¥2,500.00JP¥2,100.00n/a5
Aug ’25JP¥2,574.50
JP¥2,314.00
-10.1%
7.1%JP¥2,500.00JP¥2,100.00n/a5
Jul ’25JP¥2,380.00
JP¥2,367.50
-0.5%
5.9%JP¥2,500.00JP¥2,170.00n/a4
Jun ’25JP¥2,503.00
JP¥2,517.50
+0.6%
14.2%JP¥3,100.00JP¥2,170.00n/a4
May ’25JP¥2,283.00
JP¥2,542.00
+11.3%
16.2%JP¥3,100.00JP¥2,000.00n/a5
Apr ’25JP¥2,457.50
JP¥2,582.00
+5.1%
14.1%JP¥3,100.00JP¥2,200.00n/a5
Mar ’25JP¥2,600.00
JP¥2,602.00
+0.08%
15.1%JP¥3,200.00JP¥2,200.00n/a5
Feb ’25JP¥2,775.50
JP¥2,568.00
-7.5%
16.8%JP¥3,200.00JP¥2,040.00n/a5
Jan ’25JP¥2,663.50
JP¥2,568.00
-3.6%
16.8%JP¥3,200.00JP¥2,040.00n/a5
Dec ’24JP¥2,582.50
JP¥2,648.33
+2.5%
16.3%JP¥3,200.00JP¥2,040.00n/a6
Nov ’24JP¥2,537.00
JP¥2,726.67
+7.5%
14.4%JP¥3,200.00JP¥2,010.00JP¥2,611.006
Oct ’24JP¥2,540.00
JP¥2,810.00
+10.6%
13.8%JP¥3,200.00JP¥2,010.00JP¥2,680.006
Sep ’24JP¥2,648.50
JP¥3,010.00
+13.6%
7.6%JP¥3,400.00JP¥2,700.00JP¥2,679.005
Aug ’24JP¥2,826.00
JP¥3,070.00
+8.6%
8.7%JP¥3,400.00JP¥2,700.00JP¥2,574.505
Jul ’24JP¥2,751.50
JP¥3,070.00
+11.6%
8.7%JP¥3,400.00JP¥2,700.00JP¥2,380.005
Jun ’24JP¥2,671.00
JP¥2,933.33
+9.8%
10.5%JP¥3,500.00JP¥2,500.00JP¥2,503.006
May ’24JP¥2,769.00
JP¥2,966.67
+7.1%
9.9%JP¥3,500.00JP¥2,500.00JP¥2,283.006
Apr ’24JP¥2,666.00
JP¥2,980.00
+11.8%
10.7%JP¥3,500.00JP¥2,500.00JP¥2,457.505
Mar ’24JP¥2,663.00
JP¥2,980.00
+11.9%
10.7%JP¥3,500.00JP¥2,500.00JP¥2,600.005
Feb ’24JP¥2,752.00
JP¥3,040.00
+10.5%
13.9%JP¥3,800.00JP¥2,500.00JP¥2,775.505
Jan ’24JP¥2,881.00
JP¥3,040.00
+5.5%
13.9%JP¥3,800.00JP¥2,500.00JP¥2,663.505
Dec ’23JP¥2,779.00
JP¥2,986.67
+7.5%
16.7%JP¥4,000.00JP¥2,500.00JP¥2,582.506
Nov ’23JP¥2,777.00
JP¥3,086.67
+11.2%
17.2%JP¥4,000.00JP¥2,500.00JP¥2,537.006

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

Daiken Medical

JP¥14.4b

Engages in the manufacture and distribution of medical devices and equipment in Japan and internationally.

7775

JP¥502.00

7D

-0.6%

1Y

-3.5%

FINDEX

JP¥20.6b

Offers medical systems, office systems, and Healthtech products in Japan.

3649

JP¥804.00

7D

-5.3%

1Y

-10.7%

Charm Care

JP¥40.0b

Engages in nursing care business.

6062

JP¥1,226.00

7D

1.6%

1Y

2.9%